REQUEST A DEMO
Total
USD $0.00
Search more companies

Haseeb Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Haseeb Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Haseeb Pharmaceuticals Private Limited is an unlisted company, incorporated on 13/04/1999. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24230MH1999PTC119395 and registration number is 119395. The company is a hospital and medical care company, it is engaged in other hospital and medical care activities.

Legal Address
F-9/15 Midc Indl Areahingna Road
Nagpur; Maharashtra; Postal Code: 440016

Contact Details: Purchase the Haseeb Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Haseeb Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Haseeb Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Haseeb Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 13, 1999
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Haseeb Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.52%
Total operating revenue
-0.88%
Operating profit (EBIT)
-18.44%
EBITDA
-16.86%
Net Profit (Loss) for the Period
-28.48%
Total assets
11.44%
Total equity
7.89%
Operating Profit Margin (ROS)
-0.69%
Net Profit Margin
-1.03%
Return on Equity (ROE)
-7.48%
Debt to Equity Ratio
64.72%
Quick Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?